Key Investment Highlights

Glycotope is a well-financed, mature biotech company backed by renowned German life sciences investors. With our leading technology platform, four products in clinical development and over 200 employees at two sites in Berlin and Heidelberg, Glycotope is one of the most innovative biotech companies in Europe.

For further information, please contact:
T / +49 (30) 9489 2600
  • 2015
    Octapharma becomes shareholder as part of exclusive licensing deal
  • 2013
    Start of phase IIb studies for CetuGEX® and PankoMab and major financing round of EUR 55 m
  • 2012
    Start of phase II study with FSH-GEX® and financing round of EUR 15 m
  • 2011
    Financing round of EUR 16 m
  • 2008
    Acquisition of GMP production facility in Heidelberg and financing round of EUR 10 m
  • 2007
    First major financing round of EUR 36 m
  • 2000
    Foundation and start-up financing

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein product manufacturers in the world and has been committed to patient care and medical innovation since 1983. Its core business is the development and production of human proteins from human plasma and human cell lines.

Octapharma has 48 subsidiaries and representative offices and employs approximately 6,000 people worldwide to support the treatment of patients in over 100 countries with products across the therapeutic areas, Haematology (coagulation disorders), Immunotherapy (immune disorders) and Critical Care. The Company owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.

Octapharma became a shareholder of Glycotope as part of the exclusive worldwide license agreement on human blood coagulation factors signed between the two companies in October 2015.

View website

Eckert Life Science Accelerator (ELSA), a spin-off of Eckert Wagniskapital und Frühphasenfinanzierung, is a Berlin-based life science incubator with over two decades of experience in the venture capital industry. ELSA invests primarily in start-up companies that are in need of first-round venture capital financing and actively supports them during the transformation process from start-ups into mature and valuable companies. Eckert & Ziegler AG and Glycotope GmbH are its two most renowned and successful co-foundings and investments.

View website

Athos Group is a highly regarded provider of trust and corporate services for private clients, entrepreneurs and family owned businesses. Athos Group operates as an international trust boutique with offices in key locations worldwide, including Cyprus, Czech Republic, Estonia, Liechtenstein, Luxembourg, Malta, The Netherlands, Switzerland, the UK and the Caribbean.
As an independent group, we work with a selection of tax and legal firms as well as wealth managers and (private) banks. This gives us the opportunity and freedom to work with the existing advisors of our clients; or to introduce clients and their associates to sound international (tax) lawyers and banks in all the relevant jurisdictions.
Athos Group is proud to serve reputable families, entrepreneurs and their companies around the globe. We believe in adding value by providing a top quality service with a personal approach and fair pricing.

View website